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Ehlers-Danlos syndroIne type IV (EDS type IV) re-
sults froIn heterozygosity for Illutations in the
COL3Al gene that encodes the chains of type III
procollagen. By using light, transIllission, and scan-
ning electron Illicroscopy, we exanlined skin biopsies
from 22 individuals with EDS type IV in WhOIll the
COL3Al mutations had been identified. The IllOSt
striking changes in EDS type IV were correlated with
point Illutations that substituted a residue for a gly-
cine near the carboxyl-terminal end of the triple-
helical domain of proal(III). In three cases with the
Inutation GI012R, GI018V, or GI021E, cells in the
dermis had extrel11ely dilated rough endoplaslnic re-
ticulum (RER), the derIllis was thin, and there was a
reduced proportion of collagen although the propor-
tion of elastic fibers appeared increased. In these
E hIers-Dan los syndrome (EJ S) type IV is a dominantlyi~lherite~, connectiv.e tissue disorder ,charactel'ized. ?ytissue fi·tablhty and IIlcreaslllg age-related susceptlblhtyto rupture of arteries, the bowel, and the gravid uterus(Beighton, 1993, Steinmann CI nl. 1993). Typically the
skill appears thin, the venous architecture is often more apparent
than normal, and the skin is easily bruised. Cultured dermal
fibroblasts from individuals with the clinical features of EDS type
IV synthesize altered type III procollagen, which Illay be poorly
secreted or processed (Pope el nl, 1975; Byers et nl, 1981). Muta-
oons in the COL3A I gene, located at 2q31--q32, include I11ulti-
exon deletions, splice-junction mutations that result in exon skip-
pi.ng or other alterations in sequence, nnd point mutations that
result in substitutions for glycine within the triple helical domnin
(summarized in Steinmann el nl, 1993; Byers, '1995a, 1995b;
Kuivaniemi el nl, 1995).
The mechanisms by which alterations in type III procollagen
tructure and processing alfect tissue structure and integrity arc
poorly understood. Laurent and Agache (1974) and Holbrook and
Byers (1981) noted that fibroblastic cells in the skin of some
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tissues, collagen fibrils were SIllall (65-80 nm) COIll-
pared to norIllal (95-110 nIll). Fibrils 80-90 nIll in
diameter and moderately dilated RER were found
with Illutations G769R, G373R, and G061E and with
exon-skipping mutations of exons 34 and 45. With
Illutations G034R and G016C and exon-skipping IllU-
tations that deleted the sequences of exons 7, 8, 14,
18, 24, and 27, fibrils were Illore variable in size
(85-120 nm). The composite collagen fibrils charac-
teristic of EDS types I and II were not found in EDS
type IV. These findings indicate that Illutations in the
COL3Al gene have effects on secretion, fibrillogen-
esis, and skin architecture that reflect the position
and nature of the l11utation. Ke}' lVords: jibJ'illogellesis/
type III collagell/collagell sylltlJesisIjiIJl'oblast/perivQswlar
/IIat,··ix. ] Illvest DU/llatol 108:241-247, 1997
individuals with EDS type rv have dilated rough endoplasmic
reticulum (RER) that contains abnormal type III procollagen
molecules (Byers ei nl, 1979); in those individuals collagen fibril
diameters in skin were sm,,)1. In some other people with EDS type
IV, cellular architecture was not altered, and small fibrils (Hausser
and Anton-Lamprecht, 199-1) or fibrils of varied diameters (Byers el
nl, 1979) were observed in skin. These observed differences in cell
morphology and fibril architecture suggested that the nature or
location of the underlying mutation influenced tissue structure. To
define how mutations could nffect cell architecture, collagen fibril
stru ture, and skin morphology, we examined skin frOI11 22 indj-
vidunls with EDS rype rv who had 18 different mutations ill the
COL3A 1 gene. In tills group, RER dilatation and small collagen
fibrils in the dennis were more common with mutations nenr the
carbox")r1-terminal end of the triple helix, whereas variable fibril
diameter reflected mutations more amino-terminal ill the triple-
helical domain.
MATERJALS AND METHODS
Tissue Samples Skin biopsies of the upper inner arm were obtained with
appropriate consent from individnals with ED lype IV and /Tom unaffected
control subjects.
Light and Electron Microscopy Skin biopsies were either fixed at the
Lime of biopsy or frozen in Dnlbecco's modified E<tgle's medium with 7.5%
.dimethyl sulfoxide (OM 0) and stored for £i'Olll one to several years in
liquid nitrogen prior to thawing ~lI1d fixing. The biopsies \vcrc fixed ill
sodiulll cacodylate bufrer containing 2.5% glutaraldehyde and 2%, parafor-
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Table 1. Skin Thickness, Fibril Diameter, and Dilatation ofRER Are Variable in EDS Type IV
--------
SaJ11plc
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
lS
19
2U
21
22
Age (y)
22
20
II
36
III
35
40
31
24
.,
26
JlI
9
25
22
34
IR
2
24
30
24
35
24
17
Fibril
Scx COL3AI Mutation Skin (nll11)" Diameter (mm) ,l
Glycine SJlbstitJltioJl
M GOl6 1.08 ± 0.22 115 ± 16" 245
0.9 ± 0.1 117:!: 20" 735
M GU34R 1.18 ± 0.19 102 :!: 15 577
F G0341t 0.96 ± 0.11 104 ± 13 532
F GU61 E 0.78 _ 0.1'1 86 ± 15 698
F G373H. 0.74 ± 0.13 88 ± 13 900
M G373R. 0.92 ± 0.08 86 ± 16 561
G373R. 1.54 ± 0.21 102 ± 20 402
M G3731l.. 1.08 :!: 0.08 120 ± 12° 654
F G769R. 0.88 ± O.OS 84 ± 11 622
F GIOl2R 0.84 ± 0.06 78 ± 13 868
F GIOl8V 0.76 ± 0.25 71 ± 10 01 409
GIOl8V 0.66 ± 0.15 67 ± 9' 695
F Gl021E 0.77 ± 0.1 68 ± la' 1195
Exon Dcletion
F Exon 7 1.22 ± 0.16 109 ± 22" 464
M Exon 8 0.9 ± 0.12 95 ± 20 670
M Exon 1'1 0.84 ± 0.1 114 ± 14" 669
F Exon 18 0.84 ± ().06 121 ± 18' 543
0.87 ± 0.05 119 ± 16' 540
M Exon 24 0.76±0.ll 99 ± 17 753
F Exon 24 1.04 ± 0.06 110±23' 572
M ExoJl 27 1.02 ± 0.22 95 ± 16 804
M EXOll 34 0.92 :!: 0.25 90 ± 20 54U
F Exon 45 86 ± 10 661
M ExoJl 45 0.9±0.12 89 _ 10 653
Multi-exon Ddction
F Exons 34-48 1.04 _ 0.09 gO ± '10 885
2
2
I
2
2
2
2
I
2
3
3
3
3
2
3
1
2
2
I
1"
1
2
2
3
2-to-3
"The skin thickness (mean ::t SO) W~" C:lklllal"cd frolll IlH:aSlIrCIllClilS of five scctil)II~. At the 95% c:onf-iclcncc level. nOlle 0'- the EDS type IV valllc'\ for kin thickness is
.. igni,-il":ll1dr differcl1l IrOll1 the mC:11l control value or 1.25 ± 0.25 nllll (sec Table IJ).
LJ, Fibril di;lIli 'leI" (!.:IJ) 'iignifi 'antly differ-clIt from I:ollirol .. : p < 0.OU27.
, Sigllilil';Il1t1y dillcrclll 'i'OIIl c011trols: p < fLOO 1.
J Si~lIilical1L1y dilTcrclll frum l"Olltl'otS: lJ < 0.0 I.
(- Sig-nific:llltly dilfcrcllt fi'OIIl cOlltrol,,; p < n.02.
, NUllIher or fihril di:lI11clcr~ IlIC;hurCtl.
c E~Il'111 or dilation of thl' R.ER ill fibroblasts: 1. lIonll:tl: 2. sliJ!hc.ly increased: 3, cxlrclllc dilation.
/, III ,IIi .. C;I'\C. itER W;ltl norl11al ill the rClictlbr cJcfl1li1o hUI l'xlrclllely dil:)[cd in fihrohlasts in the papillar)' dermis.
, rile hiop"y \\,:1$ elll ,horL ill the reticul;H dcrllli~.
maldchydc; postfix-cd ill OSllliul11 tetraoxidc; eN "'CIt" staillccl ill satllnlted
uranyl aCCl:llC; (kh)'drntcd in a gradcd cthanol scri"s and propylen" oxid,,;
processed illio Epoll: scctiulleci: sequelllially staincd ""itil phosphotungstic
acid, ur'lII)'1 acetal·c, and lead citTate; and viewcd using a Philips 420 STEM
cl 'clron microscopc at (,l) kV (Snlith ,., of, 1992). A carbon grating replica
with 21 r.o lincs pcr '1111I (ErJlCSl F. Fullam, Latham. NY) W'IS uscd 1.0
c;:t1ibr~lte the Innf!;lliJ1catioll of rhe CICClTl)Tl micrographs. For light rnicros-
cop)'. I-f-l-nl-thick scctions wcrc stained with ltid,ardson's bluc and ob-
scrvccl by using n Zcis" phorolnicroscope. For sC;lnl1ing clectron 111icros-
COP)'. lixed specilllcllS wcr" critical point dried. ll10llllted with carbon pastc.
coalcd wit" !( Id-palladiull1. and vicwed wiill a JE L JM6300F field
Cll1issioll "c:tuning clectToll lllicro ... cupc.
Sall1ple' l"at had bet'll frozen and storcd in liquid nitrogcll prior to
fixation Wl're COlllp;ucci to salllples frotn the atne individual tlwt ,,,cre fixed
:tt tlte tilllC ofbiops)' to control fur arrit:lcrs due tu freezing and thnwing. For
two individna" with EDS t)'pc I ,thcrc wa, no significant differcncc in
~jbril di:lI11elcr when frozelJ :llJd r;tpidly processed ':ullplcs were COlltparcd
("nnpl,'s I and 15 in Table l). Qnalitativc evaluation by light ll1icroscopy
aud scanning ·Ieclron 111 icroscopy ;t1so did Jlot suggest fibcr disruptiOI1
rclatcd to (j. '"zin!( and thawing. The handling of so III " tissuc spccimens
prior to ~ixation and the fixativc varicd because biopsics werc received from
physicial1~ at a Itlllnhcr or institutions.
Sections pcqJcndiclIhlr to tile cpidennis ,vcrc taken frOtH the l"hickcSf
portion flf tbe biopsy. Skin thickness was mcasurcd at standard magnifica-
tiOIlS hy w.illg a reticule and under light I1ticroscopy using- rhe lowest level
oCthc stratllJ11 comcum 10 th ' subdl,rrnal fiJI laycr or swcnt glands to definc
the Ilt:lXiltllllll deplh. Thc a"crflg:c of IllcaSlIrCll1cnrs for fivc sections was
dctcrmincd lor eacb hiopsy.
Image Analysis Electron micrograph ofcross-scctions ofcoJlagcn ~ibrils
ill the reticular dennis wcre t;1kcll :It X30.000 l1Jagnificntiol1. Micrographs
wcm digitiz"d with an Epson 1200 scanner and Adobc Photoshop with
Scantastics softwar". Thc digitizcd images w"rc importcd into Nationa'
Institutes of Hcalth Image version 1.52, modificd by thresholding. alld
binarized, and the partidcs wcrc analyz"d to measure fibril area. U"twcen 400
Table II. Skin Thickness and Fibril Diameter in Controls
Fibril
Sa'llplc Agc (y) Sex Skill (ml1l)" diarllercr (11111) n"
I 6 M 1.16 ± 0.1'1 85 ± 5 5-17
2 8 M 1.08 ± 0.08 95 ± 5 366
3 23 F 1.06 ± 0.09 95 ± 5 62-1
4 23 M 1.16 ± 0.11 94 ± ') 598
5 24 F 1.1 ± n.07 102:!: 6 335
(j 35 M 1.46 ± 0.11 97 :!: 7 -109
7 40 I' 1.16 ± 0.18 103 ± 8 -1-15
8 42 F 1.38 ± 0.08 88:!: 8 -13\
9 43 F 1.3 ± 0.19 92 ± 9 471
10 44 F 1.5 ± 0.07 83 ± 9 50-1
11 44 F I.92 :!: 0.46 86 ± 8 48-1
12 45 F 1.1 ± 0.07 82 ± 8 -100
13 45 F 1.46 ± 0.31 92 ± 9 -123
14 45 F 1.78 ± 0.34 93 ± 8 -113
Mean 1.25 ± 0.25 91.9 ± 7.4
./ Skin lhh:kllcss (mean :t SO) was calculmcd fi'ullI l1lCaSlirCIIICllni of f-ive ~cctinl1s.
The mean or 111 ':111 V:t1I1CS was estirnal"cd I()!" skin 1·1Jickncss and ror fibril diameter ba~cd
011 tlie average of the control v~·lIl1cs.
" N\IIllhcr of fibril dia_l11erers I11c::ISUrcll.
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Figure 1. [11 EDS type IV, dermal fibroblasts have dilated RER. Electron microscopy of a dermal cell in control kin ,1h.J\\"s th" rypical size of the
RER lumen (n) (-». In EDS type IV skin with a point mutation (G03~R) (b), the IliR is normally dilated. whereas \\ ith G I0 IllY (<"). skip nlntatiom ofexun
18 (d) and e"on ~5 (c), and the multi-exon deletion 34-38 (1). the IliR is either modenaely (1),d) (-» or 1Il0re dralllatically distended (,.'J) (---'». Srnh'I",,.,
1 J.lm.
and 900 fibril diameters were measured for each specimen. These data were
exported to Excel and the fibril diameters, calculatcd as 2 (are,II1T), mcan
fibril diamcter, and standard dcviation (SD), were calculatcd. and graphs were
plotted. The SEM was <I'X,. indicating that thc samplc size was adcquate and
that the en'or ill cstillJating the ITlC;lIl diaillctcr was less than the elTor due to
measuring each fibril diameter.
Mutation Analysis Fibroblasts were cultured ftom skin biopsics. Total
RNA was isolated fi'ol11 the cultured dermal fibroblasts and reverse
transcribed into cDNA by using standard mcthods. The COL3A 1 cDNA
was screened for mutations by polyacrylamide gel dectrophoresis and
single-stranded confornlatioll polYIl'lorphiSl11 analysis of JJolynlerasc ·hail.1
rcacriou-:ullplificd fraglllCllrS of overlapping ~Cg1l1CI1l~ :dol1!-t the clltirl..'
coding region. The r 'gion of rhe gene predicted to be altercd lVas directly
sequenced, and the 1l1utarioll was continued hy n.:~rricriot1 t:117ytne digcsdol1
or by gCIl0111ic ~cquCJlcil1g ( oldst('ill t'1 a/, 1Illpubli ..hcci d~lla: Schwarze n n/,
unpnblished data).
Thc 111uratiollS idcntified ill III . individuals s[udicd included subsciruriuJts
for single glycine in the triple-helical domain (GO 16 . G034 n... G061 E.
G7691l... G I01ZR.. G IOlSV. G 1OZ'I E) (Goldstein CI (/1. unpnhlished dara).
spli 'e-junction Illutations that resldt'd in exon skipping (exons 7. 8. I~. 18.
24. 34. and ~5) (Schwarze ('/ nl. nnpublish'd dalal, and one example of a
nHllti-exon deletion. e"ollS 34 -'Ill (Vissing 1'/ nl. 1991). The glycines arc
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Figure 2. Dermal blood vessels are al-
tered in EDS type IV. Electron micrographs 
of blood vessels in cOlltrol (a) and EDS type IV 
skin wi th the mut:ltion G034 R (II) alld G I 02 1 E 
(r) show pos t capiUary venules. In the EDS 
type I V skin (II) . thcre arc iJlcreased layers of 
perivascular matrix compared to controls (a) 
(~). Endothelial ce lls (E) appear normal in all 
samples. A pericyte (I') has di lated RER (c) (~) 
and is \vithin the vessel connective tiSS lie 
sheath basal lamina (--». Scale I,mi 2 ).tnl. 
des ignated by their position in the trip le helix such tlwr GOOl is the first 
positioll of the triple helix; the position in thc prepro-O' chain can he 
dctermined by adding 167 to the number. 
RESULTS 
Collagen Fiber Density Is Decreased and Fibroblasts Are 
Altered in EDS type IV D e rmal th ickn ess ran ged from 0.66 to 
1.54 mm ill the EDS type IV skin compared to th e m ean of 1.25 :!: 
0 .25 mm fo r controls (Tables I. II) . C ompared to contro l skin 
elastic fibe rs in EDS type IV we re in creased in proportion to th e 
am o unt o f co ll agen fib ers, and co llagen fibers were fin er and more 
lo ose ly o"ga nized (da c,1 not shown). These changes reA ected the 
diminished size and amo unt o f collagen fibers in the dermis without 
a corresponding reduction in e lastic fibe rs. 
EDS type IV fibrob lasts had e ndoplasmic re ticulum that was 
dil ated to variou s extents (Fig 1) and was most manifes t in skin 
fi'om individuals ,~ith mutations near the carboxyl-termina l end of 
the triple heli x. Other cell typ es including mast cells, endothelial 
cells. macrophages, and smooth muscle cells usually did not have 
dila ted RE R; howe ver, in one case, pe ricytes of b lo od vessels and 
fibro blas ts had distinctly dilated RER. (Fig 2). In many biopsies 
che re was :1 g rea te r number o f lam ellae aro und dermal blood 
vessels. especiall y post-capillary venules (Fig 2), t l1:111 comparable 
vessels in controls. In controls post-capi ll ary venul es had two to six 
layers. and in EDS type IV post-capillary venul es had five to ten 
layers. There was no appa rent corre lation w ith type or lo cation of 
mutation and th e extent of vascu lar basement membrane zone 
ch anges in the dermjs. 
Scanning e lectron microscopy o f d e rmal colla gen sho wed fin e r 
coll agen fib ers that w e,'e less regularly o rganized than those in 
control skin . Whe re larger fibers w ere o bserved , these we re 
composed of sm aller loosely associated f,bers (Fig 3). 
CoHagen Fibril Diameters Are Small in a Subpopulation of 
EDS Type IV In skin from normal adu lts aged 23-45 y, th e 
m ean diam eter of co llagen fibrils in the re ticular dermis ranged 
fro m 82 :!: 8 to '/ 03 :!: 8 nm (mean :!: SD). T he diameters o f 
co ll agen fibri ls ill th e re tic ul ar d erm is o f individua ls with EDS type 
I V we re m o re he te rogeneous than in the contro ls and ranged from 
67 :!: 9 to 121 :!: 18 nm (Tables I , IT). W ith splice-junction 
mutati ons th at resu lted in dele tion of the sequence o f exon 45 fro m 
the mRNA and point mutations that resulted in substitutio ns o f 
othe r residues for glyciJle in the last 3 0 residues of the trip le helix. 
collagen fibril s we re uniforml y sma lle r thall no rmal 0" at t1~e sma ll 
end of the no rmal ran ge (Figs 4 and 5). All eXOn-SK.lpprng 
mutations that dele ted the seque nce o f exon 7 at the 5' end o f the 
regio n encoding the triple helix o r exo ns 14, 18 , o r 24 resulted in 
larger than normal fibril diam eters w i til an increased s ta lld ~ rd 
deviation . Point mutations that resu lte d in substitutions for gl yc rne 
near the ca rbox yl- terminal end of the trip le hdi.x resulted in small 
co llllgen fibri l d iamete rs, and those toward the cen ter and amlllo-
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terminal end o f the triple heli x were associated with fibrils o f a 
more widc ly variab le d iam c ter. Some insta nces. e .g .. mutations that 
del e ted exons 8 and 27, resu lted in coll agen fib,-ils that had no rma l 
m ean diam eter but a mu ch wide r varia rio n than normal (Table I 
Fig 5). In the c;lse of ,) Illulti-exon dele tio n of e xo llS 34- 48, th ~ 
fi bril diame te rs were w ithin the no rm al range o f size and va riability 
(Fig 5). 
T he cross-sectional shape of fibril s in ED S type IV o ften deviate d 
fi'om th e regular round ed profi les of the normal (Fig 4) , but 
changes in the surface cofltour of fibr il s were relatively subtle. 
Other structural abnormalities of coll agen fi bri ls, such as the 
composite fibri ls fo und in EDS types I, II , and III (Vogel c/ ai, 1979; 
I-Jau5se r and Anton-Laml-'recht, 1994), and no tched fibril s (Cole cl 
al. 1987) o r heirogl yphic fi brils (Smi th cf ai, 1992) fo und in ED S 
rype VII , w e re no t o bserved in EDS type IV . 
DI SCUSSIO N 
More than 50 mu tations in th e C OL3AI gene have no w been 
iden tified as the molecular basis for' EDS rype IV . These mutatio n 
resul t in substitutions fo r glyc ine a lo ng the length of til · trip lc-
he lical dom ain , skipping of sin g le exollS , inclusion of addi tiona l 
sequ ence as a result of intron inclusion o r partial intron incl usio n in 
the mR.NA, and a small number o f ll1ul ti-exo n deletions. T he 
consequ ences o f these mu tations are in cre,lsed risk for bowe l, 
Figure 3. Dermal collagen fibers arc more loosely organized ill 
EDS type IV. Scanning electron micrographs or collagcn in the reti cular 
dermis of a control (a) and EDS type IV skin with the mutation G373 R. (II) 
show densel)' orga nized lIl<lrrix ill the control (a) compa red co the looser and 
less orga nizL!d collagen fi bers ill the EDS rype IV skin (II). T he collagen 
fibers arc enmeshed in " ne,work of fin" branchcd clastic fi b 'rs. Sen /I' l>ar, 10 
).t lrl . 
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arterial, and uterine ruptl1l'e in addition to the diagnostic skin 
findings . Despite the molecular investigations, it rem ains uncertain 
how those mutations in the COL3Al gene result in such p leiotropic 
e ffects. 
The studies we have presented suggest that mutations in the 
COL3Al gene may have different effects that depend on the natll re 
and location of the sequence ch ange they induce. Substitutions for 
glycine and exon skipping mutations in the carboxyl-term;J1al end 
of the triple helix produce very m arked intracellular accnmulation 
of material in the RER. At the same time, the fibril diame ters are 
usually cOllSiderably smaller than norm al (Fig 5). In contrast, 
mutations that prodnce changes near the amino-terminal end of the 
triple-helical domain in the COL3A1 gene are associated with 
variable fibril diam eter and less evidence of in tracellular retention 
of the abnormal protein. 
Type III procollagen is a ho mo trimer of three pro-al (III) chains. 
In the face of heterozygosity for a mutation , th e products of o ne 
allele are normal , whereas those of the other are abno rmal. For a 
point mutation that produces a substitution for glycine, if normal 
assembly is assumed, one- eighth of the m o lecules will have three 
normal chain s, three- eighths wi ll ha ve o ne abnormal chain , three-
eighths will have two abnorm al chain s, and one-eigh th will ha ve 
three abnormal chains. Only the norm al m o lecules would be 
expected to be secreted no rm all y (Steinmann el nl. 1993 ) . For 
m utations that resul t in exon ski ppin g o r multi-exon deletion , both 
the normal ho mo trime r and the hOl11 otrimer of the shortened chain 
w ill be asse mbled and sccre ted norm all y, w hereas the he[crotrimers 
that contain one or two abnormal chains tend to be retain ed within 
the cell s. T he vast maj ority of collagen in the dennis is type I 
collagen, so the dcterm inatio n that mutations in the COL3Al gene 
produces altered fibri l diameter requires furthcr consideration. 
ColJagen fi brill ogenesis (Kad ler el ai, 1996) and fibril assembly 
are influenced by the typ es of collagens present, the extent of 
procollagen process ing, and interactions with cellular protei ns and 
matrix elemcnts (Birk and T relstad, 1986) . Eu-ly studics using 
cell-free systems demonstrated that fibri ls co uld be in d uced to 
sel f-asse mble when extracted coll agen (mostl y type J) was heated to 
37° C in the appropria te butre r (Gross and Kirk , 1958) . T hc fibrils 
generated in the ;11 11;1/"0 s),stem w ere of uni fo rm di ameter, however, 
unlike their ill 11 ;,1(' counterparts whose diam eters range fi'om 20 to 
200 nm (Parry and Craig, 1984). Furthe r studics using cell-fi'ee 
systems w ith pUI-ified components indicated that fibril diameter was 
regulated in part by the type and amount of collagens presen t. 
Lapiere and co-wo rkers (1975) showed that fibril diameter de-
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Figurc 4. Collagcn fibrils are variable in 
size and packing in EDS type IV. Trans-
mission electron micrographs of collagen 
fi brils in control (a) and EDS type IV with 
muta tions G034R (b), G I 018V (r), skipping of 
cxon 7 (d). skipping of cxon 27 (e), and 
deletion of exollS 34-4 8 (j) showed that 
contro l fibril s are relatively uniform in fibril 
diameter. shape. and packing (a). In skin frOI11 
the individuals with EDS typc IV, fibrils are 
smalier (c) or mOre variable in size and larger 
than controls (b,d-:/). Distorted fib ril s with 
nOl1 circ ul ar cross-sections arc also present in 
EDS type IV (d,e) . Scale bar, 0.2 J.tlll. 
creased as the amount of type III collagen increased w hen type I 
and type III collagen were mixed in a fibril-forming system. Similar 
etrects were observed in an ;11 II;tro system in w hich type I and ITI 
procollagen s along with C- and N -procollagen proteinases were 
used to start fibrils forming in a more physiologic fashion (Romanic 
et nl, 1991). In the latte r experiments, diameter size averaged 180 
nm when the fibtil was composed only of type I collagen and 
decreased to 80 nm when the molar ratio of type III procollagen to 
type I procollagen in the initial m L"Xture was 2: 1. Type V collagen, 
another constituen t of skin , also alters fibril diame ter when com-
bined w ith type I colla ge n in a cell-fi'ee system . Fiblils assembled 
sole ly from type I coll agen were the larges t; heterotypic .fi brils 
decreased in diameter as the am o unt of type V coll agen in the 
system increased (Birk ci ai, 1990). 
Collagen fibril s in skin and other tissues are cl early more 
complex than those generated by purified colJagen m olecu les ill 
cell-fi-ee systcm s beca use procoll agen processing is incomplete in 
som e parts of the dermis and in some tissu es and beca use other 
components are present. In feta l skin , for example, fibrils of 25 nm 
labe l with anti bod ies to the amin o-terminal propep tid e of type III 
procoll agen [pN (x1 (Ill)] and those against the amino-terminal 
propeptide of type 1 procollagen [pNa l (1)./. In adu lt skin, fibri ls 
w ith diameters of 25-45 nm label with antibodies to pN a l (I) but 
larger tibrils do not. T he larger fibrils of 45- 55 nm do label with the 
antibody to pN al (nr). suggesti ng that although m olecul es of type 
I co ll agc n tha t rctain the N-propeptide can ini tiate fibt; llogenesis, 
they cannot sustain the process to create larger fibrils. In stead . the 
N-propeptide mu st be cleaved to producc larger cylindrica l fibril s 
(Fl eischmaje r cr ai, 1985, 1990; Contard ct nl, 1993). Fa ilure to 
removc the N-propcptides of type , collagen cithe r;1I ,,;tro (Holmes 
ef nl, 1993) o r ;11 IJil/" in the human disorder EDS type VIlC (or 
dennatosparaxis) (Smith el nl, 1992) resu lts in ribbo n-likc fib rils. An 
antibo dy directed again st an epitope within the triple helix of type 
"' co lla gen iden tifies type lI .l collagen o nl y on the surface offibrils 
in skin , amnion , aorta , Achilles tendoll , and corn ea (Keene et ai, 
:1987). Even w hell the fibrils were disrupted witll 8 M urea to 
unmask interior epitopes, the an ti-type III co llagen an tibody re-
acte d o nly with the o ute r sll1'face o f the fibril , w hereas an antibody 
to type I coll agen was found throughout the fibr il (Holmes c/ nl, 
·1993). A mo re complete understanding of fibrillo gellesis in skin 
wi.Llnot em e rge un ti l the ro les of other mol ecules can be examin ed 
in a complex system . T hese include type V coll agen . w hich ca uses 
abn o rmali ties in forms ofEDS type I (Loug hlin el ai, 1995; Burrows 
CI ai, 1996; Toriello et ai , 1996). the fi bril-associated coll agens type 
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Figure 6. In EDS type IV, the mean fibril diameters are slualler
with mutations toward the carboxyl tern1inus and more variable
and in some cases larger with mutations toward the amino termi_
llUS of the triple-helical domain of type III collagen. M.ean fibril
diameters associated with mutations in the middle of the molecule were
within tl,e normal size range. The average ofche melll! fibril diameters and
the average of the standard deviations in control samples <Ire outlined by tlle
dotted box. 0, Point mutations; O. cxon skip mutation; 0, multi-exon
(exom 34-48) dcletjon. Mutations arc indicated in the COL3A I mR.NA
di"gram corresponding to the cxon skip (number) or point mutation
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Figure 5. In EDS type IV with glycine substitution and exon skip
mutations, the change in size and distribution of collagen fibril
diameters compared to controls depends OJ] the mutation. Collagen
fibril diameters in the reticular dermis of individuals with EDS type IV (-)
arc plotted with similar measurements for sex-matched controls (......). Point
mutations (indicated by the protein designation in the triple-helical do",ain)
and CXOTl skip rllut:niol1s (lrc sho\ovn in order fron) the 5' end of the
triple-helical domain of the COL3A 1 gene at the top to 3' end at the
hottom. G3731\. and G373H." represent unreJated individuals with the same
mutation. samples 6 and 7 in Table I. Exon 45< and 45" are unrelated
individuals, samples 20 and 2'1 in Table I. A 1l1ulti-cxon (exollS 34-48)
deletion in COL3A 1 results in a llonnal peak for coBllgen fibrjJ diameters in
the reticular dermis. The range of fibril diameters is slightly greater in EDS
type f V compared to the control.
XIl and type XIV (Lethias ef ai, 1993), proteoglycans such as
decorin, which can decrease the rate of fibrillogenesis of purified
type I colJagen fibrils ill /1;lto (Pog'any el aI, 1994), and other matrix
glycoproteins that can be examined in complex system.
Given such a complex biologic system, it is likely that there are
several determinants of fibril diameter and skin structllte in skin
from people with mutations in the COL3A 1 gene. Those with the
smaUest diameter fibrils had ll1utations ncar the 3' end of the
triple-helical coding region (Fig 6). Cells &om these individuals in
culture secrete almost no type III procolJagen. a state that is
reflected by the very marked dilatation of the RER in the cells in
skin (Byers et ai, 1981; Holbrook and Byers, 1981). The fibtils of
the temaining patients with EDS type IV-causing point mutations
either arc normal or increase in size as the mutation moves from the
carboxyl to amino terminus. This may result ftom aberrant inter-
actions with cellular or matrix components or it may be the tesult
of how mutant type HI procollagen assembles with type I procol-
lagen. Although the trend in fibril si.ze in spLicing mutations is
simili1r to that in patients with COL3Al point mutations, there is
much greater variability in fibl"i) diameter of those patients with
splicing errors in exons 7-24 than in patients with single-bi1se
substitutions. This may reflect different types of trimers that can be
secreted by the cells of this group of individuals, those that are
normal and those that contain three shortened chains, i1nd the
ability of such molecules to interi1ct with type I colJagen fibrils Or
other elements required for fibriIJogenesis.
The role of type III collagen in the formation of tissues is
uncertain. While it is an important component of fetal skin and the
early development of vessels and bowel wall, the role of type In
collagen in building the matrix of these structures is not known. It
is striking that some abnormalties in type III colJagen prodUCtion
result in very thin skin, thin arterii11 vessel wall, and bowel waIJs
that are thin to the point of translucency. These findings suggeSt
that type III collagen molecules are involved in the early formation
of structure and that abnonnaJ molecules, the paucity of normal
VOL. 108. NO.3 MARCI-I 1'I'n
molecules, and the presence of altered cells ma)' aU contribute to
defects in structure.
vVe thallk I"" illdillidllals ,";1" EDS type I V IIlh" IlrIlllid"d I"" skill salllples .fi'r
st"d)'; thl' JI")'s;I';(/IIS "'h,' SCI/t Ihe salllples; S"sall Allden"", Sle"cII BrtIIIIballgh,
and Roben U/1(lerlllOot! JOI" l'x}lcr; (celll/irni (fssisfaucc; nlld Dnle l-t/iflinllls Ivr
assislallce /{Iitll colllpllier graphics. SlIpp,)rl.li,,· I";S ,""rk ,"as pnlllided by.li/lldillg
frolll the aliollal IlIstillllCS of Healt" (AR2/557).
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